How Low Should You Go? Is Very Low LDL-C Safe?
Medscape,
As clinicians, we know that lowering low-density lipoprotein cholesterol (LDL-C) with statins alone or in combination with…
From target discovery to clinical drug development with human genetics
Health Reporter,
Evolocumab Safe and Effective Out to 5 Years: OSLER-1
TCTMD,
The study author says he has “no reservations” about prescribing PCSK9 inhibitors to patients with hypercholesterolemia.
PCSK9 inhibitor significantly reduces the risk of cardiovascular events: The FOURIER trial | 2 Minute Medicine
2 Minute Medicine ,
1. In addition to significantly lowering levels of low density lipoprotein cholesterol (LDL-C), evolocumab reduced the…